Global Next-Generation Drug-Eluting Stent Market Insights, Forecast to 2025
- QYR2722385
- 116 Pages
- September 2018
- Medical Devices
This research report categorizes the global Next-Generation Drug-Eluting Stent market by top players/brands, region, type and end user. This report also studies the global Next-Generation Drug-Eluting Stent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
The global Next-Generation Drug-Eluting Stent market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Next-Generation Drug-Eluting Stent market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Market size by Product
Cobalt Chromium
Stainless Steel
Others
Market size by End User
Hospitals
Clinics
Ambulatory Surgical Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Next-Generation Drug-Eluting Stent market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Next-Generation Drug-Eluting Stent market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Next-Generation Drug-Eluting Stent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Next-Generation Drug-Eluting Stent submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Next-Generation Drug-Eluting Stent are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Next-Generation Drug-Eluting Stent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Next-Generation Drug-Eluting Stent Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Product
1.4.2 Cobalt Chromium
1.4.3 Stainless Steel
1.4.4 Others
1.5 Market by End User
1.5.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Next-Generation Drug-Eluting Stent Market Size
2.1.1 Global Next-Generation Drug-Eluting Stent Revenue 2013-2025
2.1.2 Global Next-Generation Drug-Eluting Stent Sales 2013-2025
2.2 Next-Generation Drug-Eluting Stent Growth Rate by Regions
2.2.1 Global Next-Generation Drug-Eluting Stent Sales by Regions
2.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.2 Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers
3.1.3 Global Next-Generation Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
3.2 Next-Generation Drug-Eluting Stent Revenue by Manufacturers
3.2.1 Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2013-2018)
3.2.2 Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2013-2018)
3.3 Next-Generation Drug-Eluting Stent Price by Manufacturers
3.4 Next-Generation Drug-Eluting Stent Manufacturing Base Distribution, Product Types
3.4.1 Next-Generation Drug-Eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Next-Generation Drug-Eluting Stent Product Type
3.4.3 Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Next-Generation Drug-Eluting Stent Sales by Product
4.2 Global Next-Generation Drug-Eluting Stent Revenue by Product
4.3 Next-Generation Drug-Eluting Stent Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Next-Generation Drug-Eluting Stent Breakdown Data by End User
6 North America
6.1 North America Next-Generation Drug-Eluting Stent by Countries
6.1.1 North America Next-Generation Drug-Eluting Stent Sales by Countries
6.1.2 North America Next-Generation Drug-Eluting Stent Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Next-Generation Drug-Eluting Stent by Product
6.3 North America Next-Generation Drug-Eluting Stent by End User
7 Europe
7.1 Europe Next-Generation Drug-Eluting Stent by Countries
7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Countries
7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Next-Generation Drug-Eluting Stent by Product
7.3 Europe Next-Generation Drug-Eluting Stent by End User
8 Asia Pacific
8.1 Asia Pacific Next-Generation Drug-Eluting Stent by Countries
8.1.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Countries
8.1.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Next-Generation Drug-Eluting Stent by Product
8.3 Asia Pacific Next-Generation Drug-Eluting Stent by End User
9 Central & South America
9.1 Central & South America Next-Generation Drug-Eluting Stent by Countries
9.1.1 Central & South America Next-Generation Drug-Eluting Stent Sales by Countries
9.1.2 Central & South America Next-Generation Drug-Eluting Stent Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Next-Generation Drug-Eluting Stent by Product
9.3 Central & South America Next-Generation Drug-Eluting Stent by End User
10 Middle East and Africa
10.1 Middle East and Africa Next-Generation Drug-Eluting Stent by Countries
10.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Countries
10.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Next-Generation Drug-Eluting Stent by Product
10.3 Middle East and Africa Next-Generation Drug-Eluting Stent by End User
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Abbott Next-Generation Drug-Eluting Stent Products Offered
11.1.5 Abbott Recent Development
11.2 Biosensors International
11.2.1 Biosensors International Company Details
11.2.2 Company Business Overview
11.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Biosensors International Next-Generation Drug-Eluting Stent Products Offered
11.2.5 Biosensors International Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Company Business Overview
11.3.Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Medtronic Next-Generation Drug-Eluting Stent Products Offered
11.3.5 Medtronic Recent Development
11.4 Sorin Group
11.4.1 Sorin Group Company Details
11.4.2 Company Business Overview
11.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Sorin Group Next-Generation Drug-Eluting Stent Products Offered
11.4.5 Sorin Group Recent Development
11.5 SMT
11.5.1 SMT Company Details
11.5.2 Company Business Overview
11.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.5.4 SMT Next-Generation Drug-Eluting Stent Products Offered
11.5.5 SMT Recent Development
11.6 Terumo
11.6.1 Terumo Company Details
11.6.2 Company Business Overview
11.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Terumo Next-Generation Drug-Eluting Stent Products Offered
11.6.5 Terumo Recent Development
12 Future Forecast
12.1 Next-Generation Drug-Eluting Stent Market Forecast by Regions
12.1.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions 2018-2025
12.1.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Regions 2018-2025
12.2 Next-Generation Drug-Eluting Stent Market Forecast by Product
12.2.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Product 2018-2025
12.2.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Product 2018-2025
12.3 Next-Generation Drug-Eluting Stent Market Forecast by End User
12.4 North America Next-Generation Drug-Eluting Stent Forecast
12.5 Europe Next-Generation Drug-Eluting Stent Forecast
12.6 Asia Pacific Next-Generation Drug-Eluting Stent Forecast
12.7 Central & South America Next-Generation Drug-Eluting Stent Forecast
12.8 Middle East and Africa Next-Generation Drug-Eluting Stent Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Next-Generation Drug-Eluting Stent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Next-Generation Drug-Eluting Stent Product Picture
Table Next-Generation Drug-Eluting Stent Market Segments
Table Key Manufacturers Next-Generation Drug-Eluting Stent Covered
Table Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product 2013-2025
Figure Cobalt Chromium Product Picture
Table Major Manufacturers of Cobalt Chromium
Figure Stainless Steel Product Picture
Table Major Manufacturers of Stainless Steel
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Next-Generation Drug-Eluting Stent Report Years Considered
Figure Global Next-Generation Drug-Eluting Stent Market Size 2013-2025 (Million US$)
Figure Global Next-Generation Drug-Eluting Stent Sales 2013-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Next-Generation Drug-Eluting Stent Sales by Regions 2013-2018 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions 2013-2018
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions 2013-2018
Figure 2017 Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions
Table Global Next-Generation Drug-Eluting Stent Revenue by Regions 2013-2018 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions 2013-2018
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions 2013-2018
Figure 2017 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions
Table Global Next-Generation Drug-Eluting Stent Sales by Manufacturers (2013-2018) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturers (2013-2018)
Figure Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2013-2018) (Million USD)
Table Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2013-2018)
Figure Next-Generation Drug-Eluting Stent Value Share by Manufacturers in 2017
Table Key Manufacturers Next-Generation Drug-Eluting Stent Price (2013-2018) (USD/Unit)
Table Next-Generation Drug-Eluting Stent Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Next-Generation Drug-Eluting Stent Product Type
Table Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by Product (2013-2018)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product in 2017
Table Global Next-Generation Drug-Eluting Stent Revenue by Product (2013-2018) (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Share by Product (2013-2018)
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Product (2013-2018)
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Product in 2017
Table Next-Generation Drug-Eluting Stent Price by Product 2013-2018 (USD/Unit)
Table Global Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by End User (2013-2018)
Figure Global Sales Next-Generation Drug-Eluting Stent Market Share by End User (2013-2018)
Figure Global Sales Next-Generation Drug-Eluting Stent Market Share by End User in 2017
Figure North America Next-Generation Drug-Eluting Stent Sales Growth Rate 2013-2018 (K Units)
Figure North America Next-Generation Drug-Eluting Stent Revenue Growth Rate 2013-2018 (Million US$)
Table North America Next-Generation Drug-Eluting Stent Sales by Countries (2013-2018) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2013-2018)
Figure 2017 North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table North America Next-Generation Drug-Eluting Stent Revenue by Countries (2013-2018) (Million US$)
Table North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure United States Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure United States Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Canada Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Table North America Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure 2017 North America Next-Generation Drug-Eluting Stent Market Share by Product
Table North America Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by End User (2013-2018)
Figure 2017 North America Next-Generation Drug-Eluting Stent Market Share by End User
Figure Europe Next-Generation Drug-Eluting Stent Sales Growth Rate 2013-2018 (K Units)
Figure Europe Next-Generation Drug-Eluting Stent Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Sales by Countries (2013-2018) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Europe Next-Generation Drug-Eluting Stent Revenue by Countries (2013-2018) (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure Germany Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Germany Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure France Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure France Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure UK Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Italy Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Russia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure 2017 Europe Next-Generation Drug-Eluting Stent Market Share by Product
Table Europe Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by End User (2013-2018)
Figure 2017 Europe Next-Generation Drug-Eluting Stent Market Share by End User
Figure Asia Pacific Next-Generation Drug-Eluting Stent Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure China Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure China Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Japan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Korea Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure India Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure India Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Australia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Next-Generation Drug-Eluting Stent Market Share by Product
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Next-Generation Drug-Eluting Stent Market Share by End User
Figure Central & South America Next-Generation Drug-Eluting Stent Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Next-Generation Drug-Eluting Stent Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Sales by Countries (2013-2018) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Central & South America Next-Generation Drug-Eluting Stent Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure Brazil Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Next-Generation Drug-Eluting Stent Market Share by Product
Table Central & South America Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Next-Generation Drug-Eluting Stent Market Share by End User
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure GCC Countries Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Next-Generation Drug-Eluting Stent Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Next-Generation Drug-Eluting Stent Market Share by Product
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Next-Generation Drug-Eluting Stent Market Share by End User
Table Abbott Company Details
Table Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Recent Development
Table Biosensors International Company Details
Table Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Biosensors International Recent Development
Table Medtronic Company Details
Table Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medtronic Recent Development
Table Sorin Group Company Details
Table Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sorin Group Recent Development
Table SMT Company Details
Table SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table SMT Recent Development
Table Terumo Company Details
Table Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Terumo Recent Development
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions 2018-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Regions 2018-2025
Table Global Next-Generation Drug-Eluting Stent Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Regions 2018-2025
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by Product 2018-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Product 2018-2025
Table Global Next-Generation Drug-Eluting Stent Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Product 2018-2025
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by End User 2018-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by End User 2018-2025
Figure North America Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Next-Generation Drug-Eluting Stent Value Chain
Table Next-Generation Drug-Eluting Stent Customers List
Table Next-Generation Drug-Eluting Stent Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
